Stay updated with breaking news from Left Ventricular Dysfunction. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press release - InsightAce Analytic Pvt.Ltd - Left Appendage Occlusion Device Market Closing the Gap on Stroke Risk: The Left Atrial Appendage Occlusion Device - published on openPR.com
A randomized trial evaluating vitamin K therapy with aspirin or placebo with a left ventricular assist device shows avoiding aspirin reduced bleeding without increasing thrombotic risk.
An early demonstration of the novel artificial intelligence algorithm shows promise to estimate left ventricular ejection fraction without further invasive procedures, but not at the extremes of LVEF.
Beta-blocker treatment beyond 1 year after MI for patients without heart failure or left ventricular systolic dysfunction was not associated with improved cardiovascular outcomes in a new analysis.
Is myocardial viability testing for guiding PCI decisions currently used in the best way? A secondary analysis from the main trial suggests not.